Residual vascular risk in diabetes - Will the SPPARM alpha concept hold the key?
Details
Serval ID
serval:BIB_D94E3A861A64
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Residual vascular risk in diabetes - Will the SPPARM alpha concept hold the key?
Journal
Diabetes & metabolic syndrome
Working group(s)
International Atherosclerosis Society/R3i Foundation Consensus Panel
Contributor(s)
Fruchart J.C., Santos R.D., Yamashita S., Aikawa M., Libby P., Plutzky J., Pradhan A., Ridker P., Aguilar-Salinas C., Al Rasadi K., Amarenco P., Barter P.J., Ceska R., Corsini A., Ruscica M., Després J.P., Duriez P., Eckel R.H., Ezhov M.V., Farnier M., Ginsberg H.N., Hermans M.P., Ishibashi S., Karpe F., Kodama T., Koenig W., Krempf M., Lim S., Lorenzatti A.J., McPherson R., Nuñez-Cortes J.M., Nordestgaard B.G., Ogawa H., Packard C.J., Ponte-Negretti C.I., Reiner Ž., Sadikot S., Shimano H., Sritara P., Stock J.K., Su T.C., Susekov A.V., Tartar A., Taskinen M.R., Tenenbaum A., Tokgözoğlu L.S., Tomlinson B., Tybjærg-Hansen A., Valensi P., Vrablík M., Wahli W., Watts G.F., Yokote K., Zambon A.
ISSN
1878-0334 (Electronic)
ISSN-L
1871-4021
Publication state
Published
Issued date
2019
Peer-reviewed
Oui
Volume
13
Number
4
Pages
2723-2725
Language
english
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Publication Status: ppublish
Keywords
Diabetes Mellitus, Type 2/complications, Diabetic Angiopathies/drug therapy, Diabetic Angiopathies/etiology, Diabetic Angiopathies/metabolism, Humans, PPAR alpha/agonists, PPAR alpha/antagonists & inhibitors, Prognosis
Pubmed
Web of science
Create date
12/04/2021 13:05
Last modification date
28/05/2021 5:36